Vitamin K to prevent fractures in older women: a systematic review and economic evaluation
Stevenson M, Lloyd-Jones M, Papaioannou D
Record ID 32009100577
English
Authors' recommendations:
Study found that there is currently great uncertainty over whether vitamin K1 is more cost-effective than alendronate in preventing osteoporotic fractures in postmenopausal women. Expected value of sample information analyses indicate that a head-to-head randomised controlled trial of alendronate and vitamin K1, recruiting 2000 women per arm, would be a cost-effective use of resources
Details
Project Status:
Completed
URL for project:
http://www.hta.ac.uk/1712
Year Published:
2009
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Aged
- Aged, 80 and over
- Cost-Benefit Analysis
- Female
- Models, Econometric
- Quality-Adjusted Life Years
- Bone Density Conservation Agents
- Fractures, Bone
- Osteoporosis, Postmenopausal
- Vitamin K
- Vitamin K 1
- Vitamin K 2
- Vitamins
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2009 Queen’s Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.